← Leaderboards
Elizabeth E Krans
Magee-Women'S Res Inst And Foundation
$9,084,307
Attributed
$15,322,869
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,322,869 · 8
By mechanism
R01$12,793,453 · 4
R61$945,397 · 1
R34$709,813 · 1
K23$496,888 · 1
R21$377,318 · 1
Top collaborators
- Marian Patricia Jarlenski12 shared
- Beatriz Luna3 shared
- Ashok Panigrahy3 shared
- Yingshi Ouyang1 shared
- Yoel Sadovsky1 shared
Most similar at Magee-Women'S Res Inst And Foundation
Same institution · by research overlap
- Yoel Sadovsky$25,657,030
- Katherine P Himes$289,653
- Yingshi Ouyang$1,030,720
Others in their field
Top investigators on “Pregnancy”
- Chanza Baytop · Westat, Inc.$271,217,917
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$158,777,707
- Barbara Driver · Westat, Inc.$117,058,181
- Myron S Cohen · Family Health International$101,800,876
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
Research focus
PregnancyPostpartum PeriodWomanChildProviderOpioid Use DisorderPregnant WomenPostpartum WomenDesignBirthNeonatal Abstinence SyndromeCaringResourcesDiscipline Of ObstetricsMedicaid EligibilityPrevalenceInterviewEnrollmentCounselingBuprenorphineStructurePregnantAddictionHealthcare
Grant awards (26)
Improving Postpartum Contraceptive Decision-Making Among Women With Substance Use Disorders$623,229
R01 · FY2025 · DA · contact PI
Impact of collaborative care for pregnant persons with opioid use disorder in low-resource obstetric settings$945,397
R61 · FY2024 · DA · contact PI
Improving Postpartum Contraceptive Decision-Making Among Women With Substance Use Disorders$637,677
R01 · FY2024 · DA · contact PI
Project STEPuP: A prenatal provider education and training program to improve medication-assisted treatment use during pregnancy and maternal and child health outcomes$591,815
R01 · FY2024 · DA · contact PI
Multimodal Analysis of Gestational Health and Placental Injury in Opioid-Affected Pregnancies$3,092,159
R01 · FY2023 · DA
Improving Postpartum Contraceptive Decision-Making Among Women With Substance Use Disorders$630,489
R01 · FY2023 · DA · contact PI
Project STEPuP: A prenatal provider education and training program to improve medication-assisted treatment use during pregnancy and maternal and child health outcomes$599,320
R01 · FY2023 · DA · contact PI
Improving Postpartum Contraceptive Decision-Making Among Women With Substance Use Disorders$633,860
R01 · FY2022 · DA · contact PI
Availability, accessibility, and structure of opioid use disorder treatment and maternal and child health outcomes$613,885
R01 · FY2022 · DA
Project STEPuP: A prenatal provider education and training program to improve medication-assisted treatment use during pregnancy and maternal and child health outcomes$602,999
R01 · FY2022 · DA · contact PI
Availability, accessibility, and structure of opioid use disorder treatment and maternal and child health outcomes$767,447
R01 · FY2021 · DA
Improving Postpartum Contraceptive Decision-Making Among Women With Substance Use Disorders$713,607
R01 · FY2021 · DA · contact PI
Project STEPuP: A prenatal provider education and training program to improve medication-assisted treatment use during pregnancy and maternal and child health outcomes$608,885
R01 · FY2021 · DA · contact PI
Project STEPuP: A prenatal provider education and training program to improve medication-assisted treatment use during pregnancy and maternal and child health outcomes$634,259
R01 · FY2020 · DA · contact PI
Availability, accessibility, and structure of opioid use disorder treatment and maternal and child health outcomes$613,885
R01 · FY2020 · DA
4/7: Longitudinal Evaluation of the Impact of the COVID-19 Pandemic on High-risk New and Expectant Mothers$158,349
R34 · FY2020 · DA
Availability, accessibility, and structure of opioid use disorder treatment and maternal and child health outcomes$153,357
R01 · FY2020 · DA
Availability, accessibility, and structure of opioid use disorder treatment and maternal and child health outcomes$674,632
R01 · FY2019 · DA
2/4: Investigation of Opioid Exposure and Neurodevelopment (iOPEN)$275,732
R34 · FY2019 · DA
2/4: Investigation of Opioid Exposure and Neurodevelopment (iOPEN)$275,732
R34 · FY2019 · DA
Availability, accessibility, and structure of opioid use disorder treatment and maternal and child health outcomes$601,948
R01 · FY2018 · DA
Buprenorphine Assignment in Pregnancy: Objective Criteria$154,259
K23 · FY2018 · DA · contact PI
Buprenorphine Assignment in Pregnancy: Objective Criteria$171,750
K23 · FY2017 · DA · contact PI
Facilitating HCV Treatment through Tailored Prenatal Care for HCV Infected, Substance using Pregnant Women$194,133
R21 · FY2016 · DA · contact PI
Buprenorphine Assignment in Pregnancy: Objective Criteria$170,879
K23 · FY2016 · DA · contact PI
Facilitating HCV Treatment through Tailored Prenatal Care for HCV Infected, Substance using Pregnant Women$183,185
R21 · FY2015 · DA · contact PI